Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.56 |
| ▸ | MMP12 | P39900 | 4/20 | 0.56 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.56 |
| ▸ | MMP3 | P08254 | 1/20 | 0.56 |
| ▸ | MMP13 | P45452 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5250124 | 0.95 | MMP2 (0.61) | MMP2MMP12ADAM17MMP3MMP13 | |
| SCHEMBL5866655 | 0.82 | ADAM17 (0.46) | MMP2MMP12ADAM17MMP3MMP13 | |
| SCHEMBL5251185 | 0.80 | ADAM17 (0.62) | MMP2MMP12ADAM17MMP3MMP13 | |
| Trifluoroacetic Acid SCHEMBL5866692 | 0.80 | MMP3 (0.74) | MMP2MMP12ADAM17MMP3MMP13 | |
| Trifluoroacetic Acid SCHEMBL5866624 | 0.80 | ADAM17 (0.61) | MMP12ADAM17MMP13 | |
| Trifluoroacetic Acid SCHEMBL5866646 | 0.80 | ADAM17 (0.61) | MMP12ADAM17MMP13 | |
| Trifluoroacetic Acid SCHEMBL5866645 | 0.80 | ADAM17 (0.61) | MMP12ADAM17MMP13 | |
| Trifluoroacetic Acid SCHEMBL5866683 | 0.80 | ADAM17 (0.61) | MMP12ADAM17MMP13 | |
| Trifluoroacetic Acid SCHEMBL3966357 | 0.79 | ADAM17 (0.68) | MMP2MMP12ADAM17MMP3 | |
| SCHEMBL5252129 | 0.79 | ADAM17 (0.61) | MMP2MMP12ADAM17MMP3MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7074810-B2 | Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-07-11 | — | — | US | disclosed |
| US-20040116491-A1 | Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme | BRISTOL-MYERS SQUIBB COMPANY | 2004-06-17 | — | — | US | disclosed |